Dichloromethane → 4-(4-Chloro-3-fluoro-2-methoxyphenyl)-2-hydroxy-2-(trifluoromethyl)pentanal

HRID 1362487

Reaction equation

HRID 1362487 reaction equation
[F:1][C:2]1[C:3]([O:30][CH3:31])=[C:4]([CH:8]([CH3:29])[CH2:9][C:10]([C:25]([F:28])([F:27])[F:26])([OH:24])[CH:11]=NC2C=CC=C3C=2C=CC(C)=N3)[CH:5]=[CH:6]C=1.B(Br)(Br)Br.C([O-])(O)=[O:37].[Na+].[CH2:41]([Cl:43])Cl>>[Cl:43][C:41]1[CH:6]=[CH:5][C:4]([CH:8]([CH3:29])[CH2:9][C:10]([OH:24])([C:25]([F:26])([F:27])[F:28])[CH:11]=[O:37])=[C:3]([O:30][CH3:31])[C:2]=1[F:1]

Participants

5

Conditions

Temperature
-5 °C

Procedure

100 mg (0.3 mmol) of 4-(4-chloro-3-fluoro-2-methoxyphenyl)-2-hydroxy-2-(trifluoromethyl)pentanal, 48 mg (0.3 mmol) of 5-amino-2-methylquinazoline and 0.1 ml of titanium tetraethoxide are stirred in 9 ml of toluene at 100° C. for 2 h. After cooling, the mixture is poured into water and stirred vigorously. The suspension is filtered through Celite, the filter bed being rinsed thoroughly with ethyl acetate. The phases of the filtrate are separated and extraction is carried out again with ethyl acetate. The extracts are dried over sodium sulphate and the solvent is removed in vacuo to give 130 mg of 4-(3-fluoro-2-methoxyphenyl)-1-[(2-methylquinolin-5-yl)imino]-2-(trifluoromethyl)pentan-2-ol as a crude product. 130 mg of the crude imine in 6 ml of CH2Cl2 are admixed dropwise at −30° C. with 3 ml (3 mmol) of a 1 M of boron tribromide solution. The batch is allowed to warm to −5° C. over 3 hours. It is admixed with saturated NaHCO3 solution, the phases are separated, the aqueous phase is extracted with ethyl acetate and the combined organic phases are dried (Na2SO4) and concentrated in vacuo. Column chromatography on silica gel (hexane/ethyl acetate 0-75%) yields 30 mg as a mixture of the title compound and 5α,6α,8β)-3-chloro-2-fluoro-8-methyl-5-[(2-methylquinazolin-5-yl)amino]-6-(trifluoromethyl)-5,6,7,8-tetrahydronaphthalene-1,6-diol (Ex. 23). Preparative thin-layer chromatography on amine phase (Merck) with ethyl acetate/methanol/triethylamine 25:3:1 yields 5 mg of product.

Workup

  1. customthe phases are separated
  2. extractionthe aqueous phase is extracted with ethyl acetate
  3. dry with materialthe combined organic phases are dried (Na2SO4)
  4. concentrationconcentrated in vacuo
  5. customColumn chromatography on silica gel (hexane/ethyl acetate 0-75%) yields 30 mg

Sources & evidence

ORD record
ord-e19bf8a964f1490c94230e3b11daf3c5
Source dataset
uspto-grants-2011_02
Patent number
US07880042B2

Linked notes

Loading…